奥皮卡治疗与帕金森病相关的睡眠障碍:OASIS临床试验
Joaquim J Ferreira1,2, Miguel F Gago3,4,5, Raquel Costa6
1IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Journal of Parkinson's disease
|February 20, 2025
概括
在帕金森病 (PD) 患者中,50毫克的阿皮卡显著改善了睡眠障碍,并减少了运动波动的OFF时间. 这项研究提供了欧皮卡作为PD睡眠问题的治疗证据.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 睡眠障碍是帕金森病 (PD) 中普遍存在的非运动症状.
- 有限证据表明,有效的治疗方法针对PD患者的睡眠障碍,这些患者经历了运动波动.
研究的目的:
- 评估50毫克奥皮卡在缓解帕金森病患者睡眠障碍的疗效,这些患者在剂量结束时有运动波动.
- 评估阿皮卡对运动和非运动症状以及整体生活质量的影响.
主要方法:
- OASIS试验是一项开放式,单臂研究,涉及PD患者,患者在剂量结束时出现运动波动和睡眠问题.
- 主要终点:从基线到第6周的帕金森病睡眠量表2 (PDSS-2) 评分的变化.
- 二级终点包括各种运动功能,非运动症状,疲劳,生活质量和患者/临床医生的总体印象等等级.
主要成果:
- 在第6周,50毫克的奥皮卡导致PDSS-2总得分 (-7.9分) 和睡眠干扰域 (-4.7分) 的显著降低.
- 在疲劳 (PFS-16),非运动症状 (MDS-NMS),运动功能 (MDS-UPDRS-III),运动波动 (MDS-UPDRS-IV) 和生活质量 (PDQ-8) 中也注意到了显著的改善.
- 绝对OFF时间减少了142.1分钟,高患者 (93.3%) 和临床医生 (80.0%) 报告了改善.
结论:
- 将50毫克的奥皮卡添加到列沃多巴/DDCI治疗中,有效地改善了PD患者的睡眠障碍.
- 奥皮卡对睡眠质量和运动波动都有积极影响,并改善了非运动症状和生活质量.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
187
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
187
REM Sleep Behavior Disorder
130
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
130
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
Substance Use Disorders Affecting Sleep
155
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
155
Parkinson's Disease: Overview
429
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
429
Narcolepsy
88
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
88


